These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7653724)

  • 1. [Hormonal therapy in perimenopause].
    Zaĭdieva IaZ
    Akush Ginekol (Mosk); 1995; (3):28-30. PubMed ID: 7653724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the combined hormonal replacement drug estradiol valerate/levonorgestrel on climacteric complaints, endometrium and lipid profile of peri- and postmenopausal women.
    Georgiev DB; Golbs S; Goudev A
    Methods Find Exp Clin Pharmacol; 2001 May; 23(4):197-202. PubMed ID: 11676228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effects of hormone replacement therapy with estradiol valerate and cyproterone acetate in perimenopausal women].
    Tinelli FG; Tinelli A; Sena T
    Minerva Ginecol; 2002 Feb; 54(1):67-73. PubMed ID: 11828273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Replacement hormonal therapy: effects on ECG parameters in postmenopausal women].
    Zatikian EP; Smetnik VP; Klimenchenko NI
    Ter Arkh; 1998; 70(10):33-7. PubMed ID: 9864801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study between estradiol valerate combined with cyproterone acetate, and conjugated equine estrogens combined with medroxyprogesterone acetate as hormone replacement therapy in climacteric].
    Carranza-Lira S; Martínez-Chéquer JC; Río de la Loza F; Murillo-Uribe A; Celis C
    Ginecol Obstet Mex; 2000 Nov; 68():442-7. PubMed ID: 11195956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of a sequential combination of estradiol valerate and cyproterone acetate on the functional properties of the arterial wall in menopausal women].
    Mares P; Dauzat M; Abramovici Y; Deklunder G; Body G; Crepin G; Denis A; Favier M
    Gynecol Obstet Fertil; 2000; 28(7-8):509-17. PubMed ID: 10996962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experiences with Climen in peri- and postmenopausal women].
    Husmann F
    Zentralbl Gynakol; 1997; 119(3):123-7. PubMed ID: 9173770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in psychic and somatic well-being and cognitive capabilities of peri- and postmenopausal women after the use of a hormone replacement drug containing estradiol valerate and levonorgestrel.
    Rudolph I; Zimmermann T; Kaminski K; Jandova K; Borovsky B; Ahrendt HJ; Golbs S
    Methods Find Exp Clin Pharmacol; 2000; 22(1):51-6. PubMed ID: 10791296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
    Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicenter study of Klimonorm (R) by the Jenapharm firm for treating the climacteric syndrome].
    Czekanowski R; Stelmachow J; Radowicki S; Cekański A; Florczak M; Chlabicz P
    Ginekol Pol; 1995 Apr; 66(4):237-45. PubMed ID: 8529942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term sequential treatment with combined estradiol valerate and cyproterone acetate in early postmenopause.
    Polatti F; Capuzzo E; Viazzo F; Colleoni R; Abbiati I; Nappi RE
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):49-53. PubMed ID: 9926892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of the hormone replacement drug estradiol valerate/levonorgestrel in the treatment of menopausal syndrome in Thai women.
    Chittacharoen A; Domhardt R; Manonai J; Golbs S
    Methods Find Exp Clin Pharmacol; 2003 Oct; 25(8):645-51. PubMed ID: 14671683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of estrogen supplementation on psychological variables in climacteric women].
    Gramegna G; Blümel JE; Jara S; Schiattino I; Lolas F
    Rev Med Chil; 1996 Oct; 124(10):1240-4. PubMed ID: 9239913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy.
    Riis BJ; Jensen J; Christiansen C
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):327-34. PubMed ID: 2820619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estradiol valerate/cyproterone acetate in the treatment of climacteric syndrome].
    Zivný J; Skrenková J
    Ceska Gynekol; 1996 Oct; 61(5):294-6. PubMed ID: 9004975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Question of a Colleague. Can I still give advice to my wife about hormone replacement?].
    Seifert-Klauss V
    MMW Fortschr Med; 2002 Oct; 144(44):18. PubMed ID: 12494594
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pregnancy and hormone replacement therapy in a patient with resistant ovary syndrome].
    Nawroth F; Sudik R
    Zentralbl Gynakol; 1999; 121(5):255-7. PubMed ID: 10408080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical-physiological characteristics and hormone therapy of patients with typical form of climacteric syndrome].
    Gudkova MA; Kulakov VI; Krymskaia ML; Solov'eva AD
    Akush Ginekol (Mosk); 1994; (6):49-52. PubMed ID: 7892951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.